Navigation Links
Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
Date:9/17/2009

ied by such statements. There can be no guarantee that Valturna will be approved for sale in any additional markets. Nor can there be any guarantee that Tekturna will be approved for any additional indications or labeling in any market. Neither can there be any guarantee that Valturna, Tekturna or Diovan will achieve any particular levels of revenue in the future. In particular, management's expectations regarding these products could be affected by, among other things, unexpected regulatory actions or delays or government regulation generally; unexpected clinical trial results, including unexpected new clinical data and unexpected additional analysis of existing clinical data; competition in general; government, industry and general public pricing pressures; the company's ability to obtain or maintain patent or other proprietary intellectual property protection; the impact that the foregoing factors could have on the values attributed to the Novartis Group's assets and liabilities as recorded in the Group's consolidated balance sheet, and other risks and factors referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About Novartis Pharmaceuticals Corporation

Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including those in the cardiovascular, metabolic, cancer, organ transplantation, central nervous system, dermatolo
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
2. Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension
3. Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation
4. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
5. Novartis Oncology Launches GIST Alliance™ for Patients and Caregivers
6. Novartis Oncology Launches GIST Alliance™ for Healthcare Professionals Treating Gastrointestinal Stromal Tumors
7. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
8. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
9. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
10. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
11. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... San Francisco, CA (PRWEB) December 17, 2014 ... the Stanford Center for Longevity, today, in reaction to a ... the emerging science of brain training and derogated the efficacy ... said that they agreed with the parts of the center’s ... however, they believed the center had also overstated its case, ...
(Date:12/17/2014)... IL (PRWEB) December 17, 2014 Now ... Awards celebrate the best of the best in senior ... award is only given to communities and agencies that ... the SeniorAdvisor.com site. Of the nearly 100,000 providers currently ... award. Winners of the SeniorAdvisor.com Best of 2015 Awards ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. ... diseases, one worrisome phenomenon is when an illness that originated ... known as zoonosis -- is not uncommon and keeps researchers ... animal-borne disease might make inroads into the human population. ... and the culprits in this case were guinea pigs. More ...
(Date:12/17/2014)... 2014 (HealthDay News) -- Greater participation in music classes ... Researchers followed kids in the nonprofit Harmony Project, ... in Los Angeles. Over two years, children who ... how the brain processes speech and reading, compared to ... benefits of active participation in music classes occurred in ...
(Date:12/17/2014)... Kathleen Doheny HealthDay ... Chronic sleep loss is rampant in America, and work commitment ... is the No. 1 sleep killer," said Dr. Mathias Basner, ... the University of Pennsylvania Perelman School of Medicine. A ... older, found that work is the main activity exchanged for ...
Breaking Medicine News(10 mins):Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 2Health News:The Inn at Willow Falls - Crest Hill, IL Wins 2015 Best of Assisted Living Award from SeniorAdvisor.com 3Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Music Classes Boost Language Skills, Study Says 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3
... Fla., Oct. 12 After helping thousands of patients get their ... Tampa, Scottsdale, and soon in Philadelphia, the Laser Spine Institute ... facilities -- in Beverly ... Fla., in October -- which aim to meet ...
... shot for kicking nicotine addiction , MONDAY, Oct. 12 (HealthDay ... a $10 million grant to a Maryland company to help ... anti-nicotine vaccine. , Nabi Biopharmaceuticals of Rockville will launch ... The study, which could be the last step of research ...
... ... ... -- Gary C. Baker was recently hired to energize the role of Chief Financial ... quality improvement and care management organization. Mr. Baker brings his extensive experience in re-engineering ...
... WEST PALM BEACH, Fla., Oct. 12 The inaugural ... specialties was called an unqualified success by those that ... attended, the meeting was a great learning opportunity and ... Bootcamp LLC and its corporate partners. Attendees came ...
... LAS VEGAS, Oct. 12 Noninvasive Medical Technologies, ... remote patient monitoring solutions, is pleased to commit its support ... highly motivated men in two man teams are currently relay ... ruck sacks and a memorial plaque with Staff Sgt. Tim ...
... cells are being used to help develop a heart muscle ... have achieved a first step toward growing a living "heart ... embryonic stem cells, Duke University bioengineers performed a series of ... into heart muscle. , The researchers used a special mold ...
Cached Medicine News:Health News:Laser Spine Institute Helping Patients with Debilitating Back Pain at New Medical Consultation Facilities in Beverly Hills and Fort Lauderdale 2Health News:Stop-Smoking Vaccine in the Works 2Health News:Gary C. Baker Named KePRO Chief Financial Officer 2Health News:Gary C. Baker Named KePRO Chief Financial Officer 3Health News:Noninvasive Medical Technologies Supports 824-Mile Tim Davis Special Tactics Memorial March 2Health News:Noninvasive Medical Technologies Supports 824-Mile Tim Davis Special Tactics Memorial March 3Health News:Lab Study Makes Strides in Mending Hearts 2
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... the "Electrocardiogram (ECG) Devices - Global Trends, Estimates ... http://photos.prnewswire.com/prnh/20130307/600769 Global ... million by 2016. The North America ... market share while Europe claims ...
(Date:12/15/2014)... , December 15, 2014 BerGenBio ... for aggressive drug resistant cancers, today announces that it ... private placing from new and existing investors. ... support the development of its pipeline of innovative cancer ... its lead drug candidate, BGB324, a first-in-class selective Axl ...
(Date:12/15/2014)... and BRIDGEWATER, N.J. , Dec. ... and Sanofi US (EURONEXT: SAN and NYSE: SNY) are ... to launch Cholesterol Counts , an awareness program ... their numbers, and the risks associated with high LDL-C ... www. CholesterolCounts .com to take a brief poll ...
Breaking Medicine Technology:Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 2Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 3Electrocardiogram (ECG) Devices - Global Trends, Estimates and Forecasts, 2012-2018 4BerGenBio Completes NOK90 Million Fundraising 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6
... 1 Reproductive Partners Medical Group, Inc. announces their ... a financial incentive for patients with good embryo quality ... the chance of twins by transferring a single embryo. ... is reducing the number of multiple pregnancies, even twin ...
... , ... ), a leading online retailer of health, beauty, vision, and ... day ever as customer orders were the highest in company ... Beauty.com web stores featured more special offers than in ...
Cached Medicine Technology:Reproductive Partners Announces Elective Single Embryo Transfer (eSET) Encouragement Program 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3
... TOPCON Trial Lens Set offers ... powers, featuring special corrected curve ... thickness and air spacing between ... exact correction to be read ...
... The AIT-8Bs instrument design ... The table is fully wheelchair ... loads up to 100 lbs. ... for Topcon retinal camera units ...
This isnt just another new stand weve come up with, this is absolutely revolutionary!...
The LM-990A is the most completely automatic lensemeter ever created. It even measured monocular and binocular PD automatically....
Medicine Products: